Another study reported that genomic regions which became hypomethylated prior to specific CLL treatment initiation but also after disease relapse were enriched for binding sites of several transcription factors related to CLL pathogenesis, including GATA5. Here, GATA5 is linked to B-cell chronic lymphocytic leukemia.